The presence of IDH1/IDH2 mutations helps distinguish CS from chondroblastic osteosarcoma and DDCS from undifferentiated pleomorphic sarcoma (UPS) of bone (9, 10). The gene discussed is IDH2; the disease is undifferentiated pleomorphic sarcoma.